Global & Public Health (all articles)
New study of Coronavirus variants predicts virus evolving to escape current vaccines, treatments
9 Mar, 2021 | 02:49h | UTCOriginal study: Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 – Nature
Commentary on Twitter
The B.1.351 and B.1.1.7 SARS-CoV-2 variants (first detected in South Africa and the UK, respectively) show increased resistance to antibody neutralization in laboratory experiments, according to a study in Nature. https://t.co/k0QBoeim6F pic.twitter.com/czyNYMBGxF
— Nature Portfolio (@NaturePortfolio) March 8, 2021
Editorial | Avoiding exploitation in multinational covid-19 vaccine trials
9 Mar, 2021 | 02:43h | UTCAvoiding exploitation in multinational covid-19 vaccine trials – The BMJ
Study confirms higher transmissibility of SARS-CoV-2 lineage B.1.1.7
9 Mar, 2021 | 02:47h | UTCEstimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England – Science
Commentary: Study confirms B.1.1.7 variant of SARS-CoV-2 is more transmissible – News Medical
Commentary on Twitter (thread – click for more)
Our paper “Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England” has now been published in Science (early release: https://t.co/8LRLp669LL). I’ve tweeted about this a few times before, so I’m going to focus here on some key messages. (1/8)
— Nick Davies (@_nickdavies) March 3, 2021
Ten things to consider when implementing rationing guidelines during a pandemic
9 Mar, 2021 | 02:46h | UTC
Commentary on Twitter
Rationing in #pandemic? Consider
1⃣identify scarce resources
2⃣exhaust ways to integrate
3⃣be clear/involve public
4⃣prognosis/age
5⃣responsibilities
6⃣pt goals/choice
7⃣disabilities, poverty, racism
8⃣prioritize
9⃣legal coverage
🔟impact on HCWs#COVID19 https://t.co/iSWVbqH3FY pic.twitter.com/bIoYmsSKQD— Intensive Care Medicine (@yourICM) March 7, 2021
WHO: The effects of virus variants on COVID-19 vaccines
7 Mar, 2021 | 20:09h | UTCThe effects of virus variants on COVID-19 vaccines – World Health Organization
Mask mandates and restaurant restrictions tied to fewer Covid-19 illnesses and deaths, CDC study says
7 Mar, 2021 | 20:07h | UTC
Commentary on Twitter
A new @CDCMMWR finds that state-issued mask requirements are associated with the slowing of #COVID19 cases and deaths. Wearing a well-fitting mask consistently and correctly is one of the best ways we can protect ourselves and each other. Learn more: https://t.co/8YtmIMPMY0. pic.twitter.com/BLb56SGb2g
— CDC (@CDCgov) March 5, 2021
[Preprint] Genomics and epidemiology of a novel SARS-CoV-2 lineage P.1 – “P.1 may be 1.4–2.2 times more transmissible and 25-61% more likely to evade protective immunity elicited by previous infection with non-P.1 lineages”
7 Mar, 2021 | 20:05h | UTCGenomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil – medRxiv
Commentary: Brazil variant can reinfect virus survivors; COVID-19 vaccine antibodies pass into breast milk – Reuters
[Preprint] SARS-CoV-2 P.1 variant shows resistance to antibody neutralization
7 Mar, 2021 | 19:53h | UTCIncreased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization – bioRxiv
Commentary: Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization – News Medical
[Medicine based on data leaks…] Oxford study indicates AstraZeneca vaccine is effective against SARS-CoV-2 Lineage P.1
7 Mar, 2021 | 19:48h | UTC
Commentary on Twitter
https://twitter.com/hildabast/status/1368010132781600773
[Preprint] Preliminary study shows Sinovac vaccine may not trigger sufficient antibody response to SARS-CoV-2 Lineage P.1
7 Mar, 2021 | 19:49h | UTCCommentary: Sinovac vaccine may not trigger sufficient antibody response to Brazil variant: study – Reuters
Commentary on Twitter
1) In a preprint (to the Lancet), the new Brazilian #SARSCoV2 variant P.1. was found to reduce the neutralizing ability of post-COVID-19 antibodies by about 6-fold, compared with the B lineage.https://t.co/obYmktWFXr pic.twitter.com/3IPiUjHB3l
— Jonathan Cedernaes (@JCedernaes) March 2, 2021
[Preprint] Increased risk of hospitalization associated with infection with SARS-CoV-2 Lineage B.1.1.7 in Denmark
7 Mar, 2021 | 19:46h | UTC
Commentary on Twitter (thread – click for more)
📍~64% MORE SEVERE—The already more contagious #B117 variant from 🇬🇧 is now found to increase risk of #COVID19 hospitalization by 64% versus other strains, says Denmark’s 🇩🇰 CDC. Denmark sequences every cases—their data is the best, & now most worrisome.🧵 https://t.co/F6w2JYEUnM pic.twitter.com/mngJoTBZtl
— Eric Feigl-Ding (@DrEricDing) March 4, 2021
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
7 Mar, 2021 | 19:43h | UTC
Commentary on Twitter (thread – click for more)
Very good and important new data on the UK variant and vaccine response
"B.1.1.7 is not a neutralization escape variant of concern for COVID-19 vaccines"
"B.1.1.7 is unlikely to increase the risk of SARS-CoV-2 re-infection"https://t.co/DWzwBUDwY3 @cellhostmicrobe pic.twitter.com/iQv7mL9MHq— Eric Topol (@EricTopol) March 4, 2021
New WHO/IAEA publication provides guidance on radiotherapy equipment to fight cancer
7 Mar, 2021 | 19:28h | UTCNews Release: New WHO/IAEA publication provides guidance on radiotherapy equipment to fight cancer – World Health Organization
Technical Document: Technical specifications of radiotherapy equipment for cancer treatment
🆕 guidance on the procurement of radiotherapy equipment released today in collaboration with @iaeaorg, aims to improve access to this life-saving #cancer treatment option that is still lacking in many parts of the world 🌎🌍🌏
👉 https://t.co/fnR0q3DDMq pic.twitter.com/21SHSaQGy7
— World Health Organization (WHO) (@WHO) March 5, 2021
WHO Guidance: Management of people affected by lymphatic filariasis
7 Mar, 2021 | 19:26h | UTC
Quantitatively evaluating the cross-sectoral and One Health impact of interventions: A scoping review and case study of antimicrobial resistance
7 Mar, 2021 | 19:10h | UTCInfographic: Economic evaluations of One-Health interventions: an antimicrobial resistance case study
Commentary on Twitter
An exciting paper by @nichola_naylor sets out a new way to quantitatively evaluate the #OneHealth impact of interventions, using #AMR as a case study.
Read the full paper ➡️ https://t.co/IPVoa0lTMh
Download our infographic ➡️ https://t.co/vjtjgwkkOX pic.twitter.com/lzAqbcWern— LSHTM AMR Centre (@LSHTM_AMR) March 1, 2021
Perspective | COVID-19 in 2021—Continuing Uncertainty
5 Mar, 2021 | 08:52h | UTCCOVID-19 in 2021—Continuing Uncertainty – JAMA
RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19
5 Mar, 2021 | 08:53h | UTCCommentaries: Ivermectin: Yet Another Fad Runs Into The Brick Wall Known As “Actual Science” – Brief-19 AND Ivermectin doesn’t speed recovery from mild COVID-19, study shows – CIDRAP
Video: Coronavirus Variants
5 Mar, 2021 | 08:50h | UTC
How well does the AstraZeneca vaccine work? An expert reviews the current evidence
5 Mar, 2021 | 08:49h | UTC
‘When will it end?’: How a changing virus is reshaping scientists’ views on COVID-19
5 Mar, 2021 | 08:42h | UTC‘When will it end?’: How a changing virus is reshaping scientists’ views on COVID-19 – Reuters
The short-term, middle-term, and long-term future of the coronavirus
5 Mar, 2021 | 08:38h | UTCThe short-term, middle-term, and long-term future of the coronavirus – STAT
WHO Action Framework: Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance
5 Mar, 2021 | 08:08h | UTC
WHO Report: 1 in 4 people projected to have hearing problems by 2050
4 Mar, 2021 | 08:40h | UTCNews release: WHO: 1 in 4 people projected to have hearing problems by 2050 – World Health Organization
Report: World report on hearing – World Health Organization
Executive Summary: World report on hearing – World Health Organization
Commentary on Twitter
Today is World #HearingCare Day.
Over 1.5 billion people affected by hearing loss.https://t.co/581yAtKO0f pic.twitter.com/gbJ94IwZk3— World Health Organization (WHO) (@WHO) March 3, 2021
Rapid antigen screening of asymptomatic people as a public health tool to combat COVID-19
4 Mar, 2021 | 08:56h | UTC
The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
4 Mar, 2021 | 08:59h | UTCAuthor Interview: Will COVID-19 Become a Recurrent Seasonal Disease? – JAMA